Newest NIH notices and announcements, note this list will be updated weekly so please check back for more NIH funding opportunities.
Click HERE to find previous NIH funding lists
|
Opportunity # |
Title |
Deadline |
|
Technical Assistance Webinar for PAR 22-115 and PAR 22-120: Research on Community Level Interventions for Firearm and Related Violence Injury and Mortality Prevention (CLIF-VP) |
|
|
|
Notice of NIAAA Data-Sharing Guidance for Human Subjects Grants Research Funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) [4th Revision] |
|
|
|
Notice to Extend Expiration Date for PAR-20-129: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed) |
|
|
|
Notice of Participation of the National Center for Complementary and Integrative Health (NCCIH) in PAR-21-169, "Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) |
|
|
|
Notice of Special Interest (NOSI): Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship |
April 07, 2022 |
|
|
Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional) |
July 15, 2024 |
|
|
Addressing Mental Health Disparities Research Gaps: Aggregating and Mining Existing Data Sets for Secondary Analyses (R01 Clinical Trial Not Allowed) |
October 18, 2022 |
|
|
Emergency Awards: Biocontainment Facility Improvements and Building System Upgrades to Support Pandemic Preparedness (G20 Clinical Trial Not Allowed) |
April 19, 2022 |
|
|
Cancer Control Research in Persistent Poverty Areas (U54 Clinical Trial Optional) |
July 06, 2022 |
|
|
Research on Community Level Interventions for Firearm and Related Violence, Injury and Mortality Prevention (CLIF-VP) (UG3/UH3 Clinical Trial Optional) |
April 22, 2022 |
|
|
The Role of Dentistry in the Prevention of Opioid Drug Misuse and Abuse (UG3/UH3 Clinical Trial Optional) |
May 10, 2022 |
|
|
Advancing HIV/AIDS Research at the Intersection of Oral and Mental Health (R21 Clinical Trial Not Allowed) |
July 25, 2022 |
|
|
CAPSTONE Centers for Multidisciplinary Research in Child Abuse and Neglect (P50) (Clinical Trial Optional) |
July 27, 2022 |
|
|
Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional) |
January 23, 2025 |
|
|
Screening for Cognitive Impairment: Decision-Making (U24 Clinical Trial Optional) |
July 11, 2022 |
|
|
Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed) |
May 30, 2024 |
|
|
BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed) |
June 13, 2024 |
|
|
Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed) |
May 07, 2025 |
|
|
Health Equity and the Cost of Novel Treatments for Alzheimers Disease and Related Dementias (R61/R33 Clinical Trial Not Allowed) |
July 01, 2022 |
|
|
Emergency Awards: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional) |
May 02, 2022 |
|
|
Emergency Award: RADx-UP Community-Engaged Research on Rapid SARS-CoV-2 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional) |
May 02, 2022 |
|
|
Investigating Transposable Elements and Mobile DNA as Targets of Integration for Establishing HIV Reservoirs in the Brain (R61/R33 - Clinical Trial Optional) |
August 03, 2022 |
|
|
NIDCR Mentored Career Development Award to Promote Diversity (K01 Clinical Trial Required) |
January 07, 2025 |
|
|
Integrating Mental Health Care into Health Care Systems in Low- and Middle-Income Countries (R01 Clinical Trial Optional) |
August 04, 2022 |
|
|
Biomarker Signatures of TB Infection in Young Children With and Without HIV (R01 Clinical Trial Not Allowed) |
June 08, 2022 |
|
|
Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Optional) |
December 23, 2022 |
|
|
Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R01 Clinical Trial Required) |
April 07, 2022 |
|
|
Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional) |
April 07, 2022 |
|
|
Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed) |
December 20, 2024 |
|
|
Community Engaged Research on Pregnancy Related and Associated Infections and Sepsis Morbidity and Mortality (UG3/UH3 Clinical Trial Optional) |
April 18, 2022 |
|
|
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed) |
May 07, 2025 |
|
|
Emergency Award HEAL Initiative: Optimizing Existing Evidence-Based Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional) |
March 18, 2022 |
|
|
ARDS, Pneumonia, and Sepsis Phenotyping Consortium Clinical Centers (U01 Clinical Trial Not Allowed) |
June 17, 2022 |
|
|
Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) |
January 07, 2025 |
|
|
BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) |
October 11, 2024 |
|
|
Data Harmonization, Curation and Secondary Analysis of Existing Clinical Datasets (R61/R33 Clinical Trial Not Allowed) |
March 14, 2024 |
|
|
Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional) |
January 07, 2025 |
|
|
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) |
November 5, 2024 |
|
|
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional) |
November 5, 2024 |
|
|
Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed) |
September 30, 2024 |
|
|
Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional) |
June 7, 2024 |
|
|
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed) |
January 7, 2025 |
|
|
Clinical Trial Readiness for Functional Neurological Disorders (U01 Clinical Trial Optional) |
November 5, 2024 |
|
|
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) |
September 13, 2023 |
|
|
Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed) |
June 21, 2024 |
|
|
Pilot Practice-based Research for Primary Care Suicide Prevention (R34 Clinical Trial Optional) |
June 21, 2022 |
|
|
NINDS Institutional AD/ADRD Research Training Program (T32 Clinical Trial Not Allowed) |
May 25, 2024 |
|
|
INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Exploratory/Developmental Research Grant Award (R21 Clinical Trial Not Allowed) |
November 3, 2022 |
|
|
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) |
November 5, 2024 |
|
|
National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed) |
September 28, 2023 |
|
|
Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed) |
September, 7, 2024 |
|
|
Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) |
September 10, 2024 |
|
|
New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional) |
February 22, 2024 |
|
|
Implementing and Sustaining Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Equity in Outcomes (R34 Clinical Trial Required) |
September 7, 2024 |
|
|
NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) |
September 7, 2023 |
|
|
Effectiveness of School-Based Health Centers to Advance Health Equity (R01 Clinical Trial Optional) |
January 7, 2025 |
|
|
Cancer Target Discovery and Development (CTD2) (U01 Clinical Trial Not Allowed) |
October 6, 2022 |
|
|
Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed) |
June 15, 2023 |
|
|
Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed) |
June 15, 2023 |
|
|
Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed) |
May 7, 2023 |
|
|
Large Research Projects for Prevention of Healthcare-Associated Infections (R01) |
May 26, 2025 |
|
|
Mechanisms of Alcohol Tolerance (R21/R33 Clinical Trial Optional) |
September 7, 2024 |
|
|
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required) |
March 11, 2024 |
|
|
Limited Competition: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed) |
September 7, 2024 |
|
|
NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed) |
March 4, 2024 |
|
|
NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed) |
March 4, 2024 |
|
|
HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed) |
October 10, 2023 |
|
|
NIA Postdoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F32 Clinical Trial Not Allowed) |
August 8, 2024 |
|
|
NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed) |
May 7, 2024 |
|
|
Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional) |
July 13, 2023 |
|
|
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) |
May 7, 2024 |
|
|
NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required) |
May 7, 2024 |
|
|
T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed) |
February 28, 2024 |
|
|
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional) |
May 7, 2024 |
|
|
Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional) |
May 7, 2024 |
|
|
BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional) |
February 20, 2024 |
|
|
Screening and Functional Validation of Human Birth Defects Genomic Variants (R01 Clinical Trial Not Allowed) |
May 7, 2025 |
|
|
Translational Neural Devices (UG3/UH3 - Clinical Trial Optional) |
February 20, 2024 |
|
|
NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)
|
May 7, 2024 |
|
|
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access and Manipulation to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) |
July 12, 2022 |
|
|
Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Not Allowed) |
June 21, 2023 |
|
|
Research on Autism Spectrum Disorders (R21 Clinical Trial Optional) |
March 16, 2024 |
|
|
Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) |
January 10, 2024 |
|
|
Enhancement or Sustainment of Data Science Tools for Infectious and Immune-Mediated diseases (U24 Clinical Trial Not Allowed) |
July 6, 2023 |
|
|
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed) |
May 7, 2024 |
|
|
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required) |
February 15, 2024 |
|
|
Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required) |
February 15, 2024 |
|
|
NINDS Institutional Research Training Program (T32 - Clinical Trial Not Allowed) |
May 25, 2023 |
|
|
NEI Translational Research Program (TRP) on Therapy for Visual Disorders (R24 Clinical Trial Optional) |
April 13, 2023 |
|
|
Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional) |
January 7, 2024 |
|
|
Limited Competition for the Continuation or Revision of Multisite Clinical Trial Clinical Coordinating Center (Collaborative UH3 Clinical Trial Optional) |
September 27, 2023 |
|
|
NIA MSTEM: Advancing Diversity in Aging Research through Undergraduate Education (R25 - Independent Clinical Trial Not Allowed) |
May 25, 2023 |
|
|
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed) |
May 7, 2024 |
|
|
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (T32) |
September 25, 2023 |
|
|
NIDCD Research Career Enhancement Award for Established Investigators (K18 Independent Basic Experimental Studies with Humans Required) |
January 7, 2024 |
|
|
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33 Clinical Trial Required) |
January 7, 2024 |
|
|
Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional) |
January 7, 2024 |
|
|
NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional) |
February 15, 2024 |
|
|
NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional) |
July 25, 2023 |
|
|
NIDCD Early Career Research (ECR) Award (R21 Clinical Trial Optional) |
October 26, 2023 |
|
|
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) |
October 17, 2023 |
|
|
NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required) |
January 7, 2024 |
|
|
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional) |
September 7, 2023 |
|
|
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R01 Clinical Trial Optional) |
June 15, 2022 |
|
|
Exploring the Scientific Value of Existing or New Sepsis Human Biospecimen Collections (R21/R33 - Clinical Trial Not Allowed) |
November 16, 2022 |
|
|
|
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R34 Clinical Trial Optional) |
June 15, 2022 |
|
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) |
December 2, 2022 |
|
|
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) |
September 7, 2023 |
|
|
New Technologies for the In vivo Delivery of Gene Therapeutics for an HIV Cure (R01 Clinical Trial Not Allowed) |
March 7, 2023 |
|
|
NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) |
February 24, 2023 |
|
|
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) |
October 10, 2023 |
|
|
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) |
September 13, 2023 |
|
|
Successor-in-Interest (Type 6 Parent Clinical Trial Optional) |
July 23, 2023 |
|
|
Multidisciplinary Approaches to HIV-Associated Comorbidities and Prioritizing Intervention Targets (R01 Clinical Trial Not Allowed) |
January 7, 2023 |
|
|
Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional) |
March 27, 2023 |
|
|
Otolaryngology Residency Mentored Research Pathway (R25 Clinical Trial Not Allowed) |
June 13, 2023 |
|
|
Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional) |
May 17, 2023 |
|
|
Development of the Fetal Immune System (R01 Clinical Trial Not Allowed) |
December 7, 2023 |
|
|
Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional) |
September 7, 2023 |
|
|
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) |
July 20, 2022 |
|
|
NLM Information Resource Grants to Reduce Health Disparities (G08 Clinical Trial Not Allowed) |
October 21, 2022 |
|
|
Research to Improve Native American Health (R21 Clinical Trials Optional) |
September 7, 2023 |
|
|
Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) |
September 7, 2023 |
|
|
BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional) |
July 14, 2023 |
|
|
Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed) |
November 9, 2022 |
|
|
Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) |
April 15, 2022 |
|
|
NIEHS Research Intensive Short Courses and Educational Opportunities (NIEHS RISE) (R25 Clinical Trial Not Allowed) |
November 28, 2023 |
|
|
NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional) |
November 17, 2022 |
|
|
Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects (R21 Clinical Trial Not Allowed) |
May 30, 2023 |
|
|
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) |
May 7, 2023 |
|
|
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) |
November 15, 2023 |
|
|
HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed) |
September 7, 2022 |
|
|
Behavioral Tasks Targeting Brain Systems Relevant to Anhedonia (R01 Basic Experimental Studies with Humans Required) |
September 7, 2023 |
|
|
Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01) |
July 8, 2023 |
|
|
Advancing Genomic Medicine Research (Clinical Trial Optional) (R21) |
March 13, 2023 |
|
|
Advancing Genomic Medicine Research (Clinical Trial Optional) (R01) |
March 13, 2023 |
|
|
Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 Basic Experimental Studies with Humans Required) |
March 17, 2023 |
|
|
NCCIH Natural Product Mid Phase Clinical Trial Cooperative Agreement (U01 Clinical Trial Required) |
May 7, 2023 |
|
|
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) |
May 7, 2023 |
|
|
HIV Infection of the Central Nervous System (R01 Clinical Trial Not Allowed) |
May 7, 2023 |
|
|
Substance Use/Substance Use Disorder Dissertation Research Award (R36 - Clinical Trials Optional) |
May 7, 2023 |
|
|
Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required) |
May 7, 2023 |
|
|
Independent Scientist Award (Parent K02 - Independent Clinical Trial Required) |
May 7, 2023 |
|
|
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) |
May 21, 2023 |
|
|
National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional) |
May 7, 2023 |
|
|
Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trials Not Allowed) |
May 7, 2023 |
|
|
Mechanisms and Consequences of Sleep Disparities in the U.S. (R01 - Clinical Trial Not Allowed) |
July 14, 2022 |
|
|
Catalyzing Innovation in Pediatric Pharmacology Clinical Trial Design and Resource Access (X01 Clinical Trial Not Allowed) |
March 27, 2023 |
|
|
Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed) |
July 28, 2022 |
|
|
PAR-20-150 |
NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) |
June 16, 2023 |
|
Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R01- Clinical Trial Not Allowed) |
May 7, 2023 |
|
|
Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R21- Clinical Trial Not Allowed) |
May 7, 2023 |
|
|
NIDA Small Research Grant Program (R03 Clinical Trial Required) |
May 7, 2023 |
|
|
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) |
LOI due: 30 days prior to app due date App due: August 9, 2022, February 9, 2023 |
|
|
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
LOI due: 30 days prior to app due date App due: August 9, 2022, February 9, 2023 |
|
|
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Disorder (U01 Clinical Trial Optional) |
LOI due: February 25, 2022 App due: March 25, 2022 |
|
|
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Substance Use Disorders, or Alcohol Use Disorder (U19 Clinical Trial Optional) |
LOI due: February 25, 2022 App due: March 25, 2022 |
|
|
Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase 3 - Transitional Centers (P30 Clinical Trial Optional |
May 27, 2022 |
|
|
|
Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed) |
May 26, 2022 September 27, 2022 |
|
|
Enhancing Regulatory Science for Advancing Pharmaceutical Quality and Manufacturing (U01) Clinical Trials Optional |
LOI due 30 days prior to app due date: April 3, 2022 |
|
Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) |
October 28, 2022 |
|
|
National Dental Practice-Based Research Network Infrastructure Access (X01 Clinical Trial Not Allowed) |
September 1, 2022 |
|
|
|
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) |
June 10, 2022 |
|
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Training for a Dental, Oral and Craniofacial Research Workforce (T32) |
LOI due dates: August 26, 2022 App due dates: September 26, 2022 |
|
|
Institutional Training for a Dental, Oral and Craniofacial Research Workforce (T90/R90 Independent Clinical Trial Not Allowed) |
LOI due dates: August 25, 2022 App due dates: September 26, 2022 |
|
|
BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required) |
June 8, 2022; October 11, 2022 |
|
|
Support of Competitive Research (SCORE) Research Advancement Award (SC1 Clinical Trial Not Allowed) |
May 25, 2022 |
|
|
Support of Competitive Research (SCORE) Pilot Project Award (SC2 Clinical Trial Not Allowed) |
May 25, 2022 |
|
|
Support of Competitive Research (SCORE) Research Continuance Award (SC3 Clinical Trial Not Allowed) |
May 25, 2022 |
|
|
NCMRR Early Career Research Award (R03 Clinical Trial Optional) |
March 30, 2022 |
|
|
NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32Clinical Trial Not Allowed) |
June 8,2022, and October 11, 2022 |
|
|
Integrative Research on Polysubstance Abuse and Disorder (R61/R33 Clinical Trial Optional) |
March 17, 2022, July 19, 2022, November 7, 2022 |
|
|
Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations (U01 Clinical Trial Not Allowed) |
September 15, 2022 |
|
|
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required) |
April 6, 2022, and September 8, 2022 |
|
|
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) |
April 6, 2022, and September 8, 2022 |
|
|
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required) |
April 6, 2022, and September 8, 2022 |
